𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic–induced acute pancreatitis

✍ Scribed by Fady Daniel; Philippe Seksik; Wulfran Cacheux; Raymond Jian; Philippe Marteau

Book ID
110086204
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
51 KB
Volume
10
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5-Aminosalicylic acid therapy and the ri
5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
✍ Jonathan P. Terdiman; Michael Steinbuch; William A. Blumentals; Thomas A. Ullman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: Patients with inflammatory bowel disease (ibd) affecting the colon are at increased risk of developing colorectal cancer (crc). published data are conflicting about whether 5-aminosalicylic acid (5-asa) has chemopreventive properties against ibd-related carcinogenesis. the objective

Colorectal cancer prevention in inflamma
Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update
✍ David T. Rubin; Marcia R. Cruz-Correa; Christoph Gasche; Jeremy R. Jass; Gary R. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

A roundtable consensus meeting was held to consolidate current knowledge on the etiology of colorectal cancer in patients with inflammatory bowel disease and to review current strategies, both diagnostic and preventive, specifically addressing the role of 5-aminosalicylic acid. Specific topics that